These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28550660)

  • 1. Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.
    Cather C; Pachas GN; Cieslak KM; Evins AE
    CNS Drugs; 2017 Jun; 31(6):471-481. PubMed ID: 28550660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Cessation Strategies for Smokers with Schizophrenia.
    Evins AE; Cather C
    Int Rev Neurobiol; 2015; 124():133-47. PubMed ID: 26472528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.
    Evins AE; Cather C; Laffer A
    Harv Rev Psychiatry; 2015; 23(2):90-8. PubMed ID: 25747922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants for smoking cessation.
    Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
    JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES.
    Evins AE; West R; Benowitz NL; Russ C; Lawrence D; McRae T; Maravic MC; Heffner JL; Anthenelli RM
    Psychiatr Serv; 2021 Jan; 72(1):7-15. PubMed ID: 33138708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.
    Lindson N; Chepkin SC; Ye W; Fanshawe TR; Bullen C; Hartmann-Boyce J
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013308. PubMed ID: 30997928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Hays JT; Ebbert JO
    Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine replacement therapy versus control for smoking cessation.
    Hartmann-Boyce J; Chepkin SC; Ye W; Bullen C; Lancaster T
    Cochrane Database Syst Rev; 2018 May; 5(5):CD000146. PubMed ID: 29852054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation interventions for smokers with current or past depression.
    van der Meer RM; Willemsen MC; Smit F; Cuijpers P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.